HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Pablo Matar Selected Research

Pablo Matar Research Topics

Disease

18Neoplasms (Cancer)
12/2012 - 01/2002
6Lymphoma (Lymphomas)
08/2012 - 01/2002
5Colorectal Neoplasms (Colorectal Cancer)
09/2015 - 06/2009
3Carcinoma (Carcinomatosis)
12/2012 - 06/2011
3B-Cell Lymphoma (Lymphoma, B Cell)
08/2012 - 01/2005
3Neoplasm Metastasis (Metastasis)
08/2012 - 10/2004
3Breast Neoplasms (Breast Cancer)
01/2012 - 01/2003
2Sarcoma (Soft Tissue Sarcoma)
01/2010 - 01/2003
1Body Weight (Weight, Body)
01/2010
1Cardiotoxicity
05/2008

Drug/Important Bio-Agent (IBA)

10Cyclophosphamide (Cytoxan)FDA LinkGeneric
09/2015 - 01/2002
5Interleukin-12 (IL 12)IBA
09/2015 - 12/2009
32-amino-3-chlorobutyric acidIBA
08/2012 - 01/2002
3Interleukin-10 (Interleukin 10)IBA
08/2012 - 01/2002
2Interleukin-10 ReceptorsIBA
08/2012 - 01/2005
2Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
08/2012 - 01/2005
2Lovastatin (Mevacor)FDA LinkGeneric
05/2008 - 01/2003
2Doxorubicin (Adriamycin)FDA LinkGeneric
05/2008 - 01/2003
2Proteins (Proteins, Gene)FDA Link
01/2005 - 01/2003
2ErbB Receptors (EGF Receptor)IBA
10/2004 - 04/2003
2Tyrosine Kinase InhibitorsIBA
10/2004 - 04/2003
2Gefitinib (Iressa)FDA Link
10/2004 - 04/2003
1HymecromoneIBA
09/2015
1mafosfamideIBA
08/2012
14-hydroxycyclophosphamideIBA
08/2012
1Therapeutic UsesIBA
01/2010
1Hyaluronic Acid (Hyaluronan)IBA
06/2009
1Antineoplastic Agents (Antineoplastics)IBA
05/2008
1Neoplasm Antigens (Tumor Antigens)IBA
11/2007
1Messenger RNA (mRNA)IBA
01/2005
1Complementary DNA (cDNA)IBA
10/2004
1Mitogen-Activated Protein KinasesIBA
10/2004
1DNA (Deoxyribonucleic Acid)IBA
10/2004
1Monoclonal AntibodiesIBA
10/2004
1Cetuximab (Erbitux)FDA Link
10/2004
1LigandsIBA
04/2003
1Epidermal Growth Factor (EGF)IBA
04/2003
1Neuregulin-1 (Neuregulin 1)IBA
04/2003
1HSP27 Heat-Shock ProteinsIBA
01/2003
1AngiostatinsIBA
07/2002
1PlasminogenIBA
07/2002
1Conditioned Culture MediaIBA
07/2002
1beta-galactosideIBA
01/2002
1Carrier Proteins (Binding Protein)IBA
01/2002
1Galectin 1 (LGALS1)IBA
01/2002
1CytokinesIBA
01/2002
1Alkylating AgentsIBA
01/2002

Therapy/Procedure

6Immunotherapy
09/2015 - 11/2007
4Therapeutics
08/2012 - 05/2008
4Drug Therapy (Chemotherapy)
01/2012 - 01/2002
3Immunomodulation
01/2012 - 01/2002
1Injections
01/2010